"yearstart","yearend","locationabbr","locationdesc","datasource","topic","category","question","response","age","gender","raceethnicity","riskfactor","riskfactorresponse","data_value_unit","data_value_type","data_value","data_value_footnote_symbol","data_value_footnote","low_confidence_limit","high_confidence_limit","numerator","sample_size","locationid","topicid","categoryid","questionid","responseid","datavaluetypeid","ageid","genderid","raceethnicityid","riskfactorid","riskfactorresponseid","geolocation"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02",,"63000","28","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","All ages","Female","All races","Hypertension and cataract","Yes","%","Crude Prevalence","21.28",,,"19.23","23.44","300","1500","54","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGEALL","GF","ALLRACE","RFHTCAT","RFYES","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.21",,,"0.03","0.77",,"900","16","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","IN","Indiana","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","2.58",,,"2.34","2.83",,"16400","18","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-86.1499601939996 39.7669104520004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02",,"104300","15","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.07",,"498900","53","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2014","2014","US","National","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Laser surgery","85 years and older","All genders","All races","Diabetes and AMD","Yes","%","Crude Prevalence","0",,,"0","2.6","0","100","59","TUTL","CAMDTX","QAMD","RLASER","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFDMAMD","RFYES",
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.47",,,"0.46","0.48",,"1921100","13","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.88",,,"0.67","1.14",,"6700","46","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","0-17 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.33","0","1100","13","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","65-84 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","1.35",,,"0.37","3.42","0","300","54","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFYES","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.05","0.09",,"76000","40","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Anti-VEGF injections","40-64 years","All genders","All races","Hypertension and AMD","Yes","%","Crude Prevalence","10",,,"4.42","18.76","0","100","13","TUTL","CAMDTX","QAMD","RVEGF","CRDPREV","AGE4064","GALL","ALLRACE","RFHTAMD","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","All Blindness and low vision","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.22",,,"0.21","0.23",,"744700","28","TCOND","CDXC8","QDXC8","R8_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","1.97",,,"1.84","2.11",,"38900","27","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.03",,"126100","9","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Proliferative diabetic retinopathy","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.41",,,"0.38","0.45",,"128400","13","TCOND","CDXC2","QDXC2","R2_3","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.34",,"1100","56","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.02",,"22300","47","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.91",,,"0.88","0.95",,"332700","34","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","MI","Michigan","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","13.56",,,"12.85","14.31","1200","8600","26","TUTL","CVC","QVC","RGLASS","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Contact lens or fitting","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.07","0","76800","54","TUTL","CVC","QVC","RCONTAC","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","All ages","All genders","All races","Glaucoma","Yes","%","Crude Prevalence","0.41",,,"0.26","0.6","0","5900","22","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGEALL","GALL","ALLRACE","RFGLC","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.17",,,"0.16","0.18",,"750100","28","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","All Age-related macular degeneration (AMD)","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","4.73",,,"4.13","5.39",,"4500","46","TCOND","CDXC3","QDXC3","R3_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.8",,,"0.75","0.84",,"169000","28","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.02",,"17500","56","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","8.42",,,"8.17","8.68",,"45500","50","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Laser surgery","18-39 years","Male","All races","Diabetes and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"47","TUTL","CAMDTX","QAMD","RLASER","CRDPREV","AGE1839","GM","ALLRACE","RFDMAMD","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","28.78",,,"28.03","29.53","4100","14100","27","TUTL","CVC","QVC","RVCANY","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","AZ","Arizona","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Non-Occlusive retinal vascular disease","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.62",,,"0.57","0.68",,"80400","4","TCOND","CDXC4","QDXC4","R4_6","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.763811276999 34.8659702800004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","40-64 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","3.9",,,"3.56","4.27","500","11900","13","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGE4064","GM","ALLRACE","RFHT","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.97",,,"0.92","1.01",,"187100","6","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","30.14",,,"29.42","30.86","4800","15800","22","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","All ages","Female","All races","All patients","Total","%","Crude Prevalence","4.92",,,"4.8","5.05",,"118100","15","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","IA","Iowa","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.23",,,"0.12","0.41",,"5100","19","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.13",,,"0.08","0.21",,"13000","40","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Endophthalmitis","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0","1.04",,"500","49","TCOND","CDXC13","QDXC13","R13_7","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","85 years and older","Female","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"27","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE85PLUS","GF","ALLRACE","RFHTDR","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Endothelial dystrophy (Fuchs)","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"13076400","59","TCOND","CDXC16","QDXC16","R16_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT",
"2014","2014","IA","Iowa","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Contact lens or fitting","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.85","0","400","19","TUTL","CVC","QVC","RCONTAC","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0","0.05",,"18200","28","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Anti-VEGF injections","65-84 years","All genders","All races","Age-related macular degeneration","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"47","TUTL","CAMDTX","QAMD","RVEGF","CRDPREV","AGE6584","GALL","ALLRACE","RFAMD","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","15.16",,,"15.01","15.31",,"215900","27","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.4",,,"0.37","0.43",,"196600","28","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","11.56",,,"11.32","11.8",,"68100","29","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Moderate/Severe non-proliferative diabetic retinopathy","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"348800","27","TCOND","CDXC2","QDXC2","R2_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.11",,,"0.11","0.12","700","612500","22","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","85 years and older","Male","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"22","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE85PLUS","GM","ALLRACE","RFDR","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","0-17 years","All genders","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"19","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE017","GALL","ALLRACE","RFDR","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","ID","Idaho","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","65-84 years","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"16","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE6584","GALL","ALLRACE","RFHTDR","RFYES","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.08","0.09",,"1338500","42","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","All Orbital and external disease","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","2.86",,,"2.74","2.98",,"75200","40","TCOND","CDXC14","QDXC14","R14_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","65-84 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","7.71","0","0","46","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.05",,"14100","22","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","TN","Tennessee","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.29",,,"0.28","0.3",,"649200","47","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","All Infectious and inflammatory diseases","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","2.15",,,"2.04","2.26",,"72300","53","TCOND","CDXC13","QDXC13","R13_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","All ages","Female","All races","Age-related macular degeneration","Yes","%","Crude Prevalence","9.58",,,"5.58","15.09","0","200","13","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGEALL","GF","ALLRACE","RFAMD","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.1",,,"0.09","0.12",,"128400","13","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.18",,,"0.15","0.22",,"59900","46","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","0-17 years","All genders","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","0",,,"0","7.25","0","0","47","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE017","GALL","ALLRACE","RFDMDR","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.05","0.09",,"65100","49","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.05",,"2439800","59","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT",
"2014","2014","UT","Utah","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Vision screening","40-64 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.08",,,"0.02","0.23","0","3900","49","TUTL","CSCRN","QSCRN","RSCNVIS","CRDPREV","AGE4064","GALL","ALLRACE","RFDM","RFYES","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","0-17 years","Female","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"28","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE017","GF","ALLRACE","RFHTAMD","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Early/mild diabetic retinopathy","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","1.41",,,"1.27","1.56",,"27100","34","TCOND","CDXC2","QDXC2","R2_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.23",,,"0.18","0.28",,"32800","19","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","TN","Tennessee","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.02","0.06",,"44100","47","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate imp. better eye, profound imp. lesser eye","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.02",,"4259100","59","TCOND","CDXC8","QDXC8","R8_4","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT",
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Lacrimal and orbit inflammation","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.06",,"29900","49","TCOND","CDXC13","QDXC13","R13_6","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","1.06",,,"0.97","1.16",,"45200","19","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Anti-VEGF injections","All ages","Female","All races","Age-related macular degeneration","Yes","%","Crude Prevalence","8.66",,,"5.51","12.82","0","300","29","TUTL","CAMDTX","QAMD","RVEGF","CRDPREV","AGEALL","GF","ALLRACE","RFAMD","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0","0.09",,"7700","46","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","AZ","Arizona","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.07",,"80400","4","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.763811276999 34.8659702800004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.11","0.16",,"101100","47","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an ophthalmologist or other physician","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","2.02",,,"1.91","2.14","1200","58500","22","TUTL","CUTLEX","QUTLEX","REXPHS","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Other Eye Disorders","Annual prevalence of treated other eye disorders","All Other eye disorders","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","1.1",,,"0.97","1.23",,"24900","34","TCOND","CDXC17","QDXC17","R17_ALL","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.07","0.08",,"670200","34","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.04","0.11",,"24300","49","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.53",,,"0.48","0.59",,"73900","13","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","1.87",,,"1.55","2.24",,"6300","16","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.09","0.09",,"7351000","59","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT",
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.05",,"25000","15","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.08","0.1",,"306900","26","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"56","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.4",,,"0.35","0.46",,"59000","49","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.05",,"1771300","6","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.62",,,"0.58","0.66",,"159200","50","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.56",,,"0.44","0.71",,"12500","26","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment, both eyes","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.02","0.06",,"63000","28","TCOND","CDXC8","QDXC8","R8_1","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.05",,"84300","25","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Any diagnostic eye test","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","4.31",,,"4.18","4.45","3700","86400","22","TUTL","CTEST","QTEST","RTESTANY","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","MO","Missouri","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.15",,,"0.1","0.21",,"21100","29","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","3.36",,,"3.13","3.61",,"21600","46","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","1",,,"0.92","1.09",,"51300","50","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","1.44",,,"1.36","1.54","1000","67500","29","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.13","0.14",,"3074600","6","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.03",,"22200","28","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","85 years and older","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"19","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFHTDR","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"666000","42","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.26",,,"0.21","0.31",,"40700","15","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","1.55",,,"1.52","1.59",,"519300","6","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.53",,,"0.48","0.6",,"57700","42","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","7.4","0","0","56","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","AZ","Arizona","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","All Disorders of optic nerve and visual pathways","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.25",,,"0.21","0.3",,"49600","4","TCOND","CDXC11","QDXC11","R11_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-111.763811276999 34.8659702800004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Laser surgery","18-39 years","Male","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"27","TUTL","CAMDTX","QAMD","RLASER","CRDPREV","AGE1839","GM","ALLRACE","RFHTAMD","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.05",,"15200","16","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0.18","0.19",,"1303400","6","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","18-39 years","All genders","All races","Diabetes and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"34","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE1839","GALL","ALLRACE","RFDMAMD","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.07",,"127800","40","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","28",,,"27.08","28.94","2500","9100","54","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","TN","Tennessee","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"1545800","47","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.68","0","500","29","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.25",,,"0.22","0.3",,"63900","16","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.49",,,"0.31","0.75",,"4300","16","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","65-84 years","All genders","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","16.46",,,"12.99","20.43","100","400","34","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE6584","GALL","ALLRACE","RFDMDR","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.26",,,"0.24","0.29",,"194900","26","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.23",,,"0.21","0.25",,"201100","42","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Conjunctivitis","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.16",,,"0.05","0.37",,"3100","53","TCOND","CDXC13","QDXC13","R13_3","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"760100","59","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT",
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","18.83",,,"18.44","19.22",,"38200","39","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.05","0.12",,"30200","41","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.1","0.16",,"57700","42","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.49",,,"0.47","0.51",,"567800","13","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","3.02",,,"2.96","3.08",,"319000","34","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Proliferative diabetic retinopathy","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.09","0.1",,"596200","27","TCOND","CDXC2","QDXC2","R2_3","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Early/mild diabetic retinopathy","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.1",,,"0.09","0.1",,"1018200","22","TCOND","CDXC2","QDXC2","R2_1","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.1",,,"0.09","0.11",,"406100","25","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Any diagnostic eye test","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.7",,,"0.67","0.72","3000","432500","22","TUTL","CTEST","QTEST","RTESTANY","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","MO","Missouri","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","4.97",,,"4.89","5.05",,"254800","29","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.82",,,"0.81","0.84",,"1060500","26","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","UT","Utah","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Any diagnostic eye test","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.33",,,"0.28","0.37","200","62300","49","TUTL","CTEST","QTEST","RTESTANY","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","TN","Tennessee","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.03",,"82600","47","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.38",,,"0.36","0.41",,"215900","27","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.47",,,"0.43","0.51",,"118100","15","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Non-Occlusive retinal vascular disease","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.53",,,"0.49","0.56",,"167500","54","TCOND","CDXC4","QDXC4","R4_6","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","1",,,"0.72","1.35",,"4100","16","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0.16","0.21",,"116700","25","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Optical coherence tomography","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","11.1",,,"10.1","12.17","400","3600","42","TUTL","CTEST","QTEST","ROCT","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","2.07",,,"1.9","2.25",,"26200","13","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","All ages","Female","All races","All patients","Total","%","Crude Prevalence","8.96",,,"8.94","8.97",,"17284300","59","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT",
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal vein occlusion","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.03","0.04",,"649900","27","TCOND","CDXC4","QDXC4","R4_3","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Endothelial dystrophy (Fuchs)","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.07","0.08",,"1534500","34","TCOND","CDXC16","QDXC16","R16_2","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","Retinal detachment and defects","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.21",,,"0.19","0.22",,"267300","27","TCOND","CDXC1","QDXC1","R1_1","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal arterial occlusion","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"175300","26","TCOND","CDXC4","QDXC4","R4_4","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.82",,,"0.75","0.89",,"71200","16","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","1.42",,,"1.39","1.46",,"472300","6","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","40-64 years","Female","All races","Diabetes and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"50","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE4064","GF","ALLRACE","RFDMAMD","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","1.41",,,"1.39","1.43",,"1009600","40","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","1.01",,,"0.96","1.06",,"146000","9","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02",,"70900","29","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","All Blindness and low vision","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.36",,,"0.3","0.44",,"30200","41","TCOND","CDXC8","QDXC8","R8_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.03",,"188200","16","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","85 years and older","Male","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"42","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE85PLUS","GM","ALLRACE","RFDR","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Visual pathway disorders","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"1144700","6","TCOND","CDXC11","QDXC11","R11_2","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.88",,,"0.86","0.9",,"784700","13","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","IN","Indiana","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","All Disorders of optic nerve and visual pathways","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.31",,,"0.28","0.34",,"110300","18","TCOND","CDXC11","QDXC11","R11_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-86.1499601939996 39.7669104520004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Myopic degeneration","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.03","0.06",,"129800","6","TCOND","CDXC4","QDXC4","R4_9","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"4047800","59","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT",
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"27500","47","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.02",,"30400","46","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","40-64 years","Male","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","19.59",,,"16.78","22.65","100","700","54","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE4064","GM","ALLRACE","RFDMDR","RFYES","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Severe stage","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.02",,"5902300","6","TCOND","CDXC5","QDXC5","R5_XS","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.04","0.09",,"33800","9","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.53",,,"0.24","1",,"1700","49","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","ID","Idaho","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03","0","124500","16","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"65100","49","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.22",,,"1.2","1.24",,"1131200","39","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2014","2014","US","National","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.12","0.12","31900","26444900","59","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT",
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.07","0.1",,"220100","22","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Lacrimal diseases","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.16",,,"0.07","0.29",,"6400","34","TCOND","CDXC14","QDXC14","R14_3","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"101300","54","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","2.02",,,"1.83","2.21",,"21600","54","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","5.02",,,"4.93","5.1",,"254400","53","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","1.2",,,"1.02","1.41","100","12400","29","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","18-39 years","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","1.37",,,"0.28","3.95","0","200","47","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGE1839","GALL","ALLRACE","RFHTDR","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","0-17 years","Male","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"47","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGE017","GM","ALLRACE","RFDMGLC","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","0-17 years","All genders","All races","Diabetes and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"47","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE017","GALL","ALLRACE","RFDMAMD","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.46",,,"0.44","0.48","1800","393600","28","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","UT","Utah","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an ophthalmologist or other physician","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","13.33",,,"11.87","14.89","300","2000","49","TUTL","CUTLEX","QUTLEX","REXPHS","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.33",,,"0.26","0.4",,"29100","34","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","85 years and older","Male","All races","Hypertension","Yes","%","Crude Prevalence","22.58",,,"14.55","32.42","0","100","42","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE85PLUS","GM","ALLRACE","RFHT","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.43",,,"0.39","0.47",,"95000","13","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.67",,,"0.65","0.69",,"579700","39","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"54","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.1","0.15",,"83600","42","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.24",,,"0.09","0.52",,"2500","46","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.27",,,"0.24","0.3",,"136800","25","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.06","0.07",,"1072200","27","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","TN","Tennessee","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.02",,"286800","47","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Proliferative diabetic retinopathy","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.4",,,"0.39","0.42",,"673500","59","TCOND","CDXC2","QDXC2","R2_3","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT",
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.36",,,"0.24","0.52",,"7700","46","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.38",,"1000","16","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"59000","49","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.06",,"427500","9","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.03",,"289900","53","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.11",,,"0.08","0.14",,"43500","56","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","AR","Arkansas","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.37",,,"0.32","0.43",,"54000","5","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.2744907429996 34.7486501240004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","85 years and older","Female","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"47","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE85PLUS","GF","ALLRACE","RFHTDR","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.09","0.22",,"14300","54","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.17",,,"0.14","0.2",,"73900","13","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","All ages","Male","All races","All patients","Total","%","Crude Prevalence","1.37",,,"1.34","1.41",,"526800","27","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Lacrimal diseases","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0","0.76",,"700","50","TCOND","CDXC14","QDXC14","R14_3","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.16",,,"0.12","0.21",,"33000","27","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.02","0.08",,"26200","13","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an optometrist or optician","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","8.59",,,"8.16","9.03","1400","16000","47","TUTL","CUTLEX","QUTLEX","REXOPT","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","85 years and older","All genders","All races","Cataract","Yes","%","Crude Prevalence","28.16",,,"21.62","35.47","0","200","34","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFCAT","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.33",,,"0.26","0.4",,"25700","26","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","4.12",,,"4.04","4.21","8900","215300","54","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Lacrimal and orbit inflammation","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.1",,"77100","54","TCOND","CDXC13","QDXC13","R13_6","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Anti-VEGF injections","40-64 years","Male","All races","Diabetes and AMD","Yes","%","Crude Prevalence","22.5",,,"10.84","38.45","0","0","47","TUTL","CAMDTX","QAMD","RVEGF","CRDPREV","AGE4064","GM","ALLRACE","RFDMAMD","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","ID","Idaho","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","40-64 years","Male","All races","Hypertension and glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"16","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGE4064","GM","ALLRACE","RFHTGLC","RFYES","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","VT","Vermont","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"42500","50","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.24",,,"0.15","0.37",,"8700","39","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.07","0","5200","19","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"1790200","13","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Moderate/Severe non-proliferative diabetic retinopathy","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.05",,"21300","50","TCOND","CDXC2","QDXC2","R2_2","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal arterial occlusion","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"64700","15","TCOND","CDXC4","QDXC4","R4_4","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.63",,,"0.59","0.68",,"110600","25","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","40-64 years","Male","All races","Hypertension and cataract","Yes","%","Crude Prevalence","21.08",,,"19.29","22.96","400","1900","42","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE4064","GM","ALLRACE","RFHTCAT","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.05","0.06",,"555100","29","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.26",,,"0.2","0.34",,"22300","28","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","WY","Wyoming","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","15.06",,,"14.32","15.83",,"8800","56","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.07","0.09",,"470800","42","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","IN","Indiana","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.05","0.13",,"23000","18","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-86.1499601939996 39.7669104520004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","All ages","Female","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","2.12",,,"1.52","2.88","0","1900","47","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGEALL","GF","ALLRACE","RFDMDR","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","40-64 years","Female","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","1.65",,,"1.02","2.51","0","1300","34","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGE4064","GF","ALLRACE","RFHTDR","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","US","National","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Glaucoma screening","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.01","0","444500","59","TUTL","CSCRN","QSCRN","RSCNGLA","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES",
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"128400","13","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.41",,,"1.19","1.65","100","10500","34","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.82",,,"0.59","1.11","0","5000","22","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.45",,,"0.41","0.5",,"83700","46","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","2.94",,,"2.87","3.01","6300","215300","54","TUTL","CVC","QVC","RGLASS","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.02",,"1087800","22","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.2",,,"0.13","0.29",,"14500","28","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.12","0","300","56","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an ophthalmologist or other physician","18-39 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","7.65",,,"7.03","8.31","500","6800","47","TUTL","CUTLEX","QUTLEX","REXPHS","CRDPREV","AGE1839","GF","ALLRACE","RFDM","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.27",,,"0.26","0.29",,"298900","28","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"3091900","59","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT",
"2014","2014","UT","Utah","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Vision screening","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","9.06",,,"5.83","13.28","0","300","49","TUTL","CSCRN","QSCRN","RSCNVIS","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.39",,,"0.31","0.48",,"21300","50","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.03",,"49900","49","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","MO","Missouri","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","3.26",,,"3.02","3.51",,"21100","29","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Proliferative diabetic retinopathy","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.28",,,"0.22","0.36",,"25700","26","TCOND","CDXC2","QDXC2","R2_3","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","VT","Vermont","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.61",,,"0.54","0.69",,"41300","50","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","3.95",,,"3.93","3.98",,"2133000","6","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","MI","Michigan","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.97",,,"0.89","1.06","500","49200","26","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","ID","Idaho","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","All ages","Male","All races","Diabetes and cataract","Yes","%","Crude Prevalence","35",,,"24.67","46.48","0","100","16","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGEALL","GM","ALLRACE","RFDMCAT","RFYES","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","All ages","Male","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","12.36",,,"9.67","15.48","100","500","54","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGEALL","GM","ALLRACE","RFHTDR","RFYES","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.03","0.04",,"1404000","39","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.31",,,"0.22","0.42",,"13200","26","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.44",,,"0.4","0.47",,"141400","13","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.45",,,"0.39","0.52",,"41400","28","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","All Infectious and inflammatory diseases","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.96",,,"1.89","2.03",,"141400","13","TCOND","CDXC13","QDXC13","R13_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","18-39 years","All genders","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"47","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE1839","GALL","ALLRACE","RFHTAMD","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.22",,,"0.15","0.3",,"16900","46","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.01","0.32",,"2300","49","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.11","0.18",,"44000","19","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.45",,,"0.42","0.49",,"145300","41","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","85 years and older","Female","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"54","TUTL","CVC","QVC","RGLASS","CRDPREV","AGE85PLUS","GF","ALLRACE","RFHT","RFYES","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Endophthalmitis","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.08",,"338700","34","TCOND","CDXC13","QDXC13","R13_7","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","1.04",,,"0.98","1.1",,"106100","47","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","18-39 years","All genders","All races","Hypertension and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"56","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE1839","GALL","ALLRACE","RFHTCAT","RFYES","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0.07","0.42",,"3100","53","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.15",,"2500","40","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.48",,,"0.46","0.5",,"326500","34","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","All Disorders of optic nerve and visual pathways","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.47",,,"0.36","0.61",,"12600","46","TCOND","CDXC11","QDXC11","R11_ALL","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","40-64 years","Male","All races","Glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"46","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE4064","GM","ALLRACE","RFGLC","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"675300","42","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment, both eyes","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.03","0.05",,"256300","39","TCOND","CDXC8","QDXC8","R8_1","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.18",,"2100","41","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2014","2014","IA","Iowa","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Endothelial dystrophy (Fuchs)","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.39",,,"0.24","0.6",,"5100","19","TCOND","CDXC16","QDXC16","R16_2","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","IN","Indiana","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.21",,,"0.15","0.28",,"23000","18","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-86.1499601939996 39.7669104520004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","0-17 years","Female","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","0",,,"0","9.25","0","0","42","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE017","GF","ALLRACE","RFDMDR","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.11","0.13",,"1040800","42","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","8.1",,,"8.02","8.19",,"400000","49","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.06",,"5900","13","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","All ages","All genders","All races","Diabetic retinopathy","Yes","%","Crude Prevalence","15.99",,,"14.06","18.07","200","1300","19","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGEALL","GALL","ALLRACE","RFDR","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","NY","New York","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.03",,"34100","36","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-75.5439704269996 42.8270010320004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0","0.07",,"10500","40","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal arterial occlusion","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.03",,"18600","25","TCOND","CDXC4","QDXC4","R4_4","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2013","2013","IN","Indiana","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.02",,"1098700","18","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-86.1499601939996 39.7669104520004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","All ages","Male","All races","Hypertension and AMD","Yes","%","Crude Prevalence","18.18",,,"6.98","35.46","0","0","13","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGEALL","GM","ALLRACE","RFHTAMD","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","65-84 years","Male","All races","Diabetic retinopathy","Yes","%","Crude Prevalence","24.36",,,"15.35","35.4","0","100","27","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE6584","GM","ALLRACE","RFDR","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","1.32",,,"1.18","1.47",,"23500","50","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.08",,"48300","13","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","1.54",,,"1.31","1.79",,"10500","40","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.11",,"3300","46","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Myopic degeneration","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03",,"104500","19","TCOND","CDXC4","QDXC4","R4_9","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"129800","6","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","IA","Iowa","MAX","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","Retinal detachment and defects","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.28",,,"0.19","0.39",,"12300","19","TCOND","CDXC1","QDXC1","R1_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.28",,,"0.27","0.29",,"1840200","6","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Vision screening","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","19.32",,,"18.1","20.59","800","3900","42","TUTL","CSCRN","QSCRN","RSCNVIS","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","UT","Utah","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Any diagnostic eye test","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.26",,,"0.23","0.28","400","163000","49","TUTL","CTEST","QTEST","RTESTANY","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","NY","New York","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.07",,"676400","36","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-75.5439704269996 42.8270010320004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.04","0.12",,"22200","28","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","AR","Arkansas","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.39",,,"0.36","0.42",,"171300","5","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.2744907429996 34.7486501240004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.84",,,"0.82","0.86",,"1124700","59","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT",
"2013","2013","AZ","Arizona","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Myopic degeneration","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"625600","4","TCOND","CDXC4","QDXC4","R4_9","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-111.763811276999 34.8659702800004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"137600","25","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal arterial occlusion","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"491600","42","TCOND","CDXC4","QDXC4","R4_4","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","All Infectious and inflammatory diseases","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","4.63",,,"4.56","4.69",,"400000","49","TCOND","CDXC13","QDXC13","R13_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","All Blindness and low vision","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.28",,,"0.27","0.28",,"4302600","6","TCOND","CDXC8","QDXC8","R8_ALL","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.48",,,"0.38","0.6",,"15400","49","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","US","National","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","65-84 years","Male","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence","6.66",,,"5.43","8.06","100","1500","59","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE6584","GM","ALLRACE","RFDMGLC","RFYES",
"2013","2013","VT","Vermont","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.1",,,"0.02","0.29",,"3000","50","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.04",,"244500","53","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.04",,"10300","26","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","18-39 years","Male","All races","Hypertension and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"46","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE1839","GM","ALLRACE","RFHTCAT","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.11",,,"0.1","0.12",,"627000","54","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","NY","New York","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"992100","36","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-75.5439704269996 42.8270010320004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"395800","27","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.81",,,"0.67","0.97",,"15200","16","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment, both eyes","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"299400","6","TCOND","CDXC8","QDXC8","R8_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02",,"33800","9","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.41",,,"0.29","0.56",,"9700","26","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","1.41",,,"1.28","1.55",,"31300","34","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","MO","Missouri","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","All Infectious and inflammatory diseases","All ages","Female","All races","All patients","Total","%","Crude Prevalence","3.24",,,"3.19","3.28",,"633400","29","TCOND","CDXC13","QDXC13","R13_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"411500","13","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.11",,,"0.09","0.13",,"96200","54","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"87900","16","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.71",,,"1.63","1.81",,"81300","9","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0","0.14",,"5100","56","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","65-84 years","Male","All races","Hypertension and glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"28","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE6584","GM","ALLRACE","RFHTGLC","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","All Cancer and neoplasms of the eye diseases","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"128400","13","TCOND","CDXC15","QDXC15","R15_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","Retinal detachment and defects","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02",,"105000","54","TCOND","CDXC1","QDXC1","R1_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","VT","Vermont","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"47400","50","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02",,"143400","16","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Tonometry?test","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.71","0","500","22","TUTL","CTEST","QTEST","RTONO","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","0-17 years","Male","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"46","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE017","GM","ALLRACE","RFDMDR","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.07","0.12",,"59000","49","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.64",,,"0.53","0.77",,"16900","46","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.03","0.08",,"26800","15","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.83",,,"0.66","1.04",,"9700","26","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"96200","54","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"50","TUTL","CVC","QVC","RVCANY","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Non-Occlusive retinal vascular disease","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.27",,,"0.25","0.28",,"513000","25","TCOND","CDXC4","QDXC4","R4_6","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate imp. better eye, profound imp. lesser eye","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0","0.08",,"9200","46","TCOND","CDXC8","QDXC8","R8_4","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","VT","Vermont","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"27300","50","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.84",,,"0.82","0.87",,"668800","47","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","IA","Iowa","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.18",,,"1.03","1.35",,"18900","19","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.71",,,"0.69","0.72",,"1144700","6","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Laser surgery","65-84 years","All genders","All races","Hypertension and AMD","Yes","%","Crude Prevalence","0",,,"0","1.94","0","200","34","TUTL","CAMDTX","QAMD","RLASER","CRDPREV","AGE6584","GALL","ALLRACE","RFHTAMD","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.03","0.05",,"142900","39","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Early/mild diabetic retinopathy","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0.18","0.2",,"1151700","26","TCOND","CDXC2","QDXC2","R2_1","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.59",,,"0.47","0.73",,"14300","54","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Lacrimal and orbit inflammation","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.43",,,"0.38","0.49",,"59900","46","TCOND","CDXC13","QDXC13","R13_6","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Moderate/Severe non-proliferative diabetic retinopathy","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.04",,"13200","26","TCOND","CDXC2","QDXC2","R2_2","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.45",,,"0.43","0.47",,"534500","42","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.36",,,"0.2","0.58",,"4500","46","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.33",,,"0.32","0.34",,"1303400","6","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","40-64 years","Female","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","3.08",,,"1.94","4.62","0","700","28","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGE4064","GF","ALLRACE","RFHTDR","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.05","0.08",,"143800","46","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"40700","15","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Early/mild diabetic retinopathy","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.72",,,"0.69","0.75",,"343200","6","TCOND","CDXC2","QDXC2","R2_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","0-17 years","All genders","All races","Cataract","Yes","%","Crude Prevalence","14.29",,,"4.03","32.67","0","0","50","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE017","GALL","ALLRACE","RFCAT","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","85 years and older","Male","All races","Hypertension and glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"46","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE85PLUS","GM","ALLRACE","RFHTGLC","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","AZ","Arizona","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.25",,,"0.18","0.34",,"16700","4","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.763811276999 34.8659702800004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Lacrimal diseases","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.31",,,"0.3","0.33",,"541800","42","TCOND","CDXC14","QDXC14","R14_3","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.68",,,"0.63","0.74",,"80300","46","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.26",,,"1.18","1.35",,"71200","16","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","IA","Iowa","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.04","0.05",,"497600","19","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.02",,"21300","22","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03",,"106400","34","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"8956600","59","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT",
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.05",,"7000","46","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Optical coherence tomography","All ages","Male","All races","Diabetes","Yes","%","Crude Prevalence","6.47",,,"5.81","7.19","300","5000","19","TUTL","CTEST","QTEST","ROCT","CRDPREV","AGEALL","GM","ALLRACE","RFDM","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.42",,"900","46","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.71",,,"0.23","1.65",,"700","53","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Glaucoma screening","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.05","0","6700","19","TUTL","CSCRN","QSCRN","RSCNGLA","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Endophthalmitis","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.15",,,"0.11","0.2",,"31300","34","TCOND","CDXC13","QDXC13","R13_7","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","1.49",,,"1.32","1.67",,"18500","41","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.73",,,"0.7","0.76",,"338700","34","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","65-84 years","Male","All races","Diabetes and cataract","Yes","%","Crude Prevalence","41.95",,,"34.53","49.66","100","200","34","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE6584","GM","ALLRACE","RFDMCAT","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","40-64 years","All genders","All races","Hypertension and cataract","Yes","%","Crude Prevalence","19.57",,,"17.84","21.4","400","2000","28","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE4064","GALL","ALLRACE","RFHTCAT","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","All ages","All genders","All races","Cataract","Yes","%","Crude Prevalence","17.64",,,"15.24","20.25","200","900","50","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGEALL","GALL","ALLRACE","RFCAT","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","MO","Missouri","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.47",,,"0.45","0.49",,"446500","29","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","CA","California","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","40-64 years","Female","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","2.75",,,"2.4","3.14","200","7900","6","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGE4064","GF","ALLRACE","RFHTDR","RFYES","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.59",,,"0.36","0.92",,"3200","28","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","All ages","Female","All races","All patients","Total","%","Crude Prevalence","9.67",,,"9.6","9.75","59300","612500","22","TUTL","CVC","QVC","RVCANY","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.05","0.22",,"7800","22","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","All ages","Male","All races","All patients","Total","%","Crude Prevalence","17.46",,,"17.35","17.57",,"476000","27","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Severe stage","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.03","0.03",,"2060400","26","TCOND","CDXC5","QDXC5","R5_XS","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","0-17 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","6.38","0","100","46","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","VT","Vermont","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.62",,,"0.57","0.68",,"80200","50","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","MO","Missouri","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate imp. better eye, profound imp. lesser eye","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"203800","29","TCOND","CDXC8","QDXC8","R8_4","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Other/unspecified infectious and inflammatory diseases","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.44",,,"0.39","0.49",,"83300","9","TCOND","CDXC13","QDXC13","R13_5","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Non-Occlusive retinal vascular disease","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.03",,"332700","34","TCOND","CDXC4","QDXC4","R4_6","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","WY","Wyoming","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.01","0.1",,"8800","56","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"284000","29","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.09",,"122300","49","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"132800","28","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","85 years and older","Female","All races","Diabetes and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"19","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE85PLUS","GF","ALLRACE","RFDMCAT","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.02","0.1",,"12500","26","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","40-64 years","All genders","All races","Glaucoma","Yes","%","Crude Prevalence","3.86",,,"2.93","4.98","100","1500","19","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE4064","GALL","ALLRACE","RFGLC","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","CA","California","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","0-17 years","All genders","All races","Hypertension and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"6","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE017","GALL","ALLRACE","RFHTCAT","RFYES","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.94",,,"0.9","0.97","2700","287500","54","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","65-84 years","Male","All races","Hypertension and AMD","Yes","%","Crude Prevalence","0",,,"0","11.22","0","0","42","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE6584","GM","ALLRACE","RFHTAMD","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment, both eyes","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.05",,"26200","13","TCOND","CDXC8","QDXC8","R8_1","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.32",,,"0.25","0.4",,"23400","29","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.78",,,"0.76","0.81",,"526800","27","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","65-84 years","All genders","All races","Diabetes and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"56","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE6584","GALL","ALLRACE","RFDMCAT","RFYES","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","CA","California","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","40-64 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","1.09",,,"1.05","1.13","3000","276300","6","TUTL","CVC","QVC","RVCANY","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFYES","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.74",,,"0.73","0.75",,"3074600","6","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","1.42",,,"0.68","2.6",,"700","53","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2013","2013","AR","Arkansas","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate imp. better eye, profound imp. lesser eye","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.03","0.08",,"35700","5","TCOND","CDXC8","QDXC8","R8_4","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-92.2744907429996 34.7486501240004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an optometrist or optician","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","26.97",,,"22.07","32.34","100","300","19","TUTL","CUTLEX","QUTLEX","REXOPT","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Other/unspecified infectious and inflammatory diseases","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0.14","0.26",,"25400","15","TCOND","CDXC13","QDXC13","R13_5","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","26.99",,,"25.05","29","500","2000","46","TUTL","CVC","QVC","RVCANY","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","65-84 years","Male","All races","Diabetes and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"19","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE6584","GM","ALLRACE","RFDMAMD","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","US","National","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","85 years and older","All genders","All races","Age-related macular degeneration","Yes","%","Crude Prevalence","21.06",,,"17.53","24.95","100","500","59","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFAMD","RFYES",
"2014","2014","MO","Missouri","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","0-17 years","Female","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"29","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE017","GF","ALLRACE","RFDMDR","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0","0.49",,"1100","19","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","IN","Indiana","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.5",,,"0.47","0.53",,"207300","18","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-86.1499601939996 39.7669104520004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.49",,,"0.46","0.52",,"227100","27","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","1.79",,,"1.75","1.82",,"551500","39","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.12","0.12",,"29815300","59","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT",
"2014","2014","US","National","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","2.41",,,"2.4","2.42",,"9854600","59","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT",
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.24",,,"0.11","0.45",,"3800","29","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","CA","California","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","65-84 years","All genders","All races","Diabetic retinopathy","Yes","%","Crude Prevalence","2.09",,,"1.68","2.58","100","4100","6","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGE6584","GALL","ALLRACE","RFDR","RFYES","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.1",,,"1.06","1.14",,"267300","27","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","MO","Missouri","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.05","0.13",,"25300","29","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","WY","Wyoming","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.12",,"3200","56","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","All Infectious and inflammatory diseases","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","2.9",,,"2.74","3.06",,"43600","16","TCOND","CDXC13","QDXC13","R13_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Anti-VEGF injections","0-17 years","Male","All races","Diabetes and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"27","TUTL","CAMDTX","QAMD","RVEGF","CRDPREV","AGE017","GM","ALLRACE","RFDMAMD","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Glaucoma screening","0-17 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.84","0","400","28","TUTL","CSCRN","QSCRN","RSCNGLA","CRDPREV","AGE017","GM","ALLRACE","RFHT","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.37",,,"0.33","0.41",,"98100","13","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","ID","Idaho","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","85 years and older","Female","All races","Age-related macular degeneration","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"16","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE85PLUS","GF","ALLRACE","RFAMD","RFYES","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.3",,,"0.29","0.31",,"3681000","6","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","All Age-related macular degeneration (AMD)","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.18",,,"0.16","0.19",,"431300","40","TCOND","CDXC3","QDXC3","R3_ALL","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.04","0.18",,"7900","9","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an optometrist or optician","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","10.31",,,"9.74","10.91","1100","10500","34","TUTL","CUTLEX","QUTLEX","REXOPT","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.08","0.11",,"143400","16","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","TN","Tennessee","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.7",,,"0.67","0.72",,"411000","47","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"551300","40","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","All ages","All genders","All races","Age-related macular degeneration","Yes","%","Crude Prevalence","15.89",,,"13.18","18.9","100","700","27","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGEALL","GALL","ALLRACE","RFAMD","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.27","0","1300","19","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.03",,"142500","27","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.15",,,"0.13","0.16",,"394000","26","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","US","National","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.47",,,"0.47","0.47",,"24636300","59","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT",
"2014","2014","LA","Louisiana","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Glaucoma screening","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01","0","28100","22","TUTL","CSCRN","QSCRN","RSCNGLA","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.7",,,"0.59","0.82",,"22200","28","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.21",,,"0.2","0.22",,"1176700","27","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.03","0.08",,"38200","39","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Endophthalmitis","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.02","0.08",,"20900","56","TCOND","CDXC13","QDXC13","R13_7","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.07","0.09",,"513000","25","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","All Cancer and neoplasms of the eye diseases","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"105000","54","TCOND","CDXC15","QDXC15","R15_ALL","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","18-39 years","Female","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","15.38",,,"4.36","34.87","0","0","19","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE1839","GF","ALLRACE","RFHTDR","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Visual pathway disorders","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"269400","40","TCOND","CDXC11","QDXC11","R11_2","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Optical coherence tomography","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","11.01",,,"8.71","13.66","100","700","22","TUTL","CTEST","QTEST","ROCT","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","2.89",,,"2.77","3",,"84500","34","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.2",,,"0.18","0.22",,"176300","26","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","AZ","Arizona","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.16",,,"0.14","0.19",,"134300","4","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-111.763811276999 34.8659702800004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","40-64 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.82",,,"0.72","0.93","200","30300","22","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"139900","9","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.12","0","3000","34","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.07","0.1",,"245000","47","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.04",,"22400","22","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.47",,,"0.43","0.51",,"110600","25","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Severe stage","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.07","0.1",,"226100","27","TCOND","CDXC5","QDXC5","R5_XS","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.37",,,"0.36","0.39",,"652400","29","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.02",,"27600","26","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.02",,"244500","53","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.05","0.06",,"331200","34","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"284000","29","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","11.77",,,"9.28","14.66","100","600","29","TUTL","CVC","QVC","RVCANY","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Non-Occlusive retinal vascular disease","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.11",,,"0.1","0.13",,"224800","34","TCOND","CDXC4","QDXC4","R4_6","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","NY","New York","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.21",,,"0.2","0.22",,"992100","36","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-75.5439704269996 42.8270010320004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.03","0.11",,"20300","16","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02",,"77000","13","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","US","National","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","All ages","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","27.43",,,"26.99","27.88","10500","38400","59","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGEALL","GALL","ALLRACE","RFHTDR","RFYES",
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","All Age-related macular degeneration (AMD)","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.07","0.08",,"929200","42","TCOND","CDXC3","QDXC3","R3_ALL","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.03",,"5872100","59","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT",
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.15",,,"0.13","0.16",,"191700","28","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0.17","0.2",,"245000","47","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","40-64 years","Male","All races","Glaucoma","Yes","%","Crude Prevalence","4.94",,,"3.68","6.48","0","1000","29","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE4064","GM","ALLRACE","RFGLC","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","85 years and older","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"54","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFHTDR","RFYES","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.47",,,"0.31","0.66",,"6400","19","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","NY","New York","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.03","0.03",,"1933000","36","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-75.5439704269996 42.8270010320004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.27",,,"0.26","0.28",,"1808000","59","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT",
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Lacrimal and orbit inflammation","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.13",,"2800","22","TCOND","CDXC13","QDXC13","R13_6","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.04",,"131600","26","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01","0","59000","29","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.48",,,"0.46","0.49",,"652400","29","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","5.74",,,"5.62","5.86",,"136800","25","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"24900","34","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Proliferative diabetic retinopathy","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.39",,,"0.31","0.48",,"22300","28","TCOND","CDXC2","QDXC2","R2_3","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.06","0.06",,"17654500","59","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT",
"2014","2014","MI","Michigan","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","65-84 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0.33",,,"0.07","0.97","0","900","26","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFYES","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","LA","Louisiana","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","14.92",,,"14.8","15.04",,"346800","22","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","40-64 years","All genders","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","13.83",,,"11.99","15.84","200","1300","29","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE4064","GALL","ALLRACE","RFDMDR","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an optometrist or optician","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","6.56",,,"6.51","6.61","58500","891300","29","TUTL","CUTLEX","QUTLEX","REXOPT","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","IN","Indiana","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.42",,,"0.41","0.44",,"643100","18","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-86.1499601939996 39.7669104520004)"
"2014","2014","US","National","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Optical coherence tomography","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","1.63",,,"1.62","1.65","45000","2761500","59","TUTL","CTEST","QTEST","ROCT","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT",
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","8.92",,,"8.58","9.28",,"25700","26","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.2",,,"0.18","0.21",,"472300","6","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","65-84 years","All genders","All races","Diabetic retinopathy","Yes","%","Crude Prevalence","0.71",,,"0.15","2.06","0","400","34","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE6584","GALL","ALLRACE","RFDR","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.22",,,"0.21","0.23",,"1040900","59","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT",
"2013","2013","IN","Indiana","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"537900","18","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-86.1499601939996 39.7669104520004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.07",,"72500","50","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an optometrist or optician","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","7.84",,,"7.57","8.11","3000","38900","42","TUTL","CUTLEX","QUTLEX","REXOPT","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.16",,,"0.14","0.19",,"132800","28","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","MO","Missouri","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Visual pathway disorders","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"267200","29","TCOND","CDXC11","QDXC11","R11_2","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.05","0.05",,"14263200","6","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","CA","California","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Contact lens or fitting","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.04",,,"0.03","0.04","100","359000","6","TUTL","CVC","QVC","RCONTAC","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"202500","27","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.65",,,"0.63","0.67",,"675300","42","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"332700","34","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"558100","13","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","AZ","Arizona","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.05","0.06",,"1438000","4","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.763811276999 34.8659702800004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"578300","40","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.42",,,"0.23","0.7",,"3300","56","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","MI","Michigan","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Laser surgery","All ages","Male","All races","Diabetes and AMD","Yes","%","Crude Prevalence","0",,,"0","2.49","0","100","26","TUTL","CAMDTX","QAMD","RLASER","CRDPREV","AGEALL","GM","ALLRACE","RFDMAMD","RFYES","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.26","0","1400","50","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"750100","28","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","US","National","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","18-39 years","Male","All races","Hypertension and glaucoma","Yes","%","Crude Prevalence","1.49",,,"0.79","2.53","0","900","59","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGE1839","GM","ALLRACE","RFHTGLC","RFYES",
"2014","2014","IA","Iowa","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.03","0.04",,"179300","19","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.02",,"18254400","59","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT",
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.04","0.07",,"146000","9","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal arterial occlusion","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"213800","49","TCOND","CDXC4","QDXC4","R4_4","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","UT","Utah","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","65-84 years","All genders","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"49","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGE6584","GALL","ALLRACE","RFDMGLC","RFYES","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","IN","Indiana","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.98",,,"1.88","2.09",,"69300","18","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-86.1499601939996 39.7669104520004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","1.12",,,"0.95","1.32",,"13500","16","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","0-17 years","Male","All races","Diabetes and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"50","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE017","GM","ALLRACE","RFDMCAT","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Other refraction and accommodation disorders","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.13","0.15",,"413700","19","TCOND","CDXC7","QDXC7","R7_5","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","7.55",,,"3.96","12.81","0","200","50","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","0-17 years","Male","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"28","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE017","GM","ALLRACE","RFHTDR","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","WY","Wyoming","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate imp. better eye, profound imp. lesser eye","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.01","0.23",,"3200","56","TCOND","CDXC8","QDXC8","R8_4","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","Retinal detachment and defects","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.13",,,"0.07","0.23",,"9700","46","TCOND","CDXC1","QDXC1","R1_1","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"84600","15","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.27",,"1400","56","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.08",,"331200","34","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.04","0.05",,"1124700","59","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT",
"2014","2014","US","National","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.02",,"29815300","59","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT",
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.67",,,"0.64","0.71",,"196600","28","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.56",,,"0.54","0.58",,"558100","13","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.05",,"457200","59","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT",
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.39",,"900","16","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","All ages","All genders","All races","Hypertension and cataract","Yes","%","Crude Prevalence","21.92",,,"20.71","23.17","1000","4400","34","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGEALL","GALL","ALLRACE","RFHTCAT","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.44",,"800","22","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"1338500","42","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.05","0.14",,"18200","28","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.23",,,"0.21","0.26",,"176300","26","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","18-39 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","21.6",,,"20.65","22.57","1500","7100","34","TUTL","CVC","QVC","RGLASS","CRDPREV","AGE1839","GF","ALLRACE","RFHT","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","Retinal detachment and defects","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.31",,,"0.17","0.52",,"4500","46","TCOND","CDXC1","QDXC1","R1_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","WY","Wyoming","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","All Cancer and neoplasms of the eye diseases","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.03",,"25200","56","TCOND","CDXC15","QDXC15","R15_ALL","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.52",,"700","53","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.52",,,"0.51","0.54",,"1299900","42","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.01","0.09",,"15200","16","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","All Disorders of optic nerve and visual pathways","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.48",,,"0.43","0.53",,"84300","27","TCOND","CDXC11","QDXC11","R11_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"191700","28","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"104500","19","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Color blindness","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"373200","13","TCOND","CDXC12","QDXC12","R12_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","UT","Utah","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","85 years and older","All genders","All races","Diabetes and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"49","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFDMCAT","RFYES","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"22","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.3",,,"0.24","0.37",,"31300","46","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal arterial occlusion","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"572000","22","TCOND","CDXC4","QDXC4","R4_4","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.37",,,"0.35","0.38",,"716000","39","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Other refraction and accommodation disorders","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.08",,"343600","59","TCOND","CDXC7","QDXC7","R7_5","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT",
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.05",,"513000","25","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate imp. better eye, profound imp. lesser eye","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.05",,"6900","15","TCOND","CDXC8","QDXC8","R8_4","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Color blindness","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"357100","47","TCOND","CDXC12","QDXC12","R12_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","18-39 years","All genders","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"22","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE1839","GALL","ALLRACE","RFHTAMD","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.52",,"700","53","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Lacrimal and orbit inflammation","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.05",,"10300","26","TCOND","CDXC13","QDXC13","R13_6","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.07",,"77100","54","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Any diagnostic eye test","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","9.49",,,"8.95","10.05","1100","11100","29","TUTL","CTEST","QTEST","RTESTANY","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.34",,"1100","56","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","0-17 years","Male","All races","Diabetes and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"13","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE017","GM","ALLRACE","RFDMCAT","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","85 years and older","All genders","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"54","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFHT","RFYES","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","All Disorders of optic nerve and visual pathways","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.31",,,"0.23","0.4",,"18000","16","TCOND","CDXC11","QDXC11","R11_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Conjunctivitis","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","4.89",,,"4.58","5.22",,"17700","15","TCOND","CDXC13","QDXC13","R13_3","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.39",,,"0.35","0.43",,"88000","22","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03",,"55400","34","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","2.59",,,"2.45","2.73",,"51700","27","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.48",,,"0.46","0.5",,"357100","47","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Other/unspecified orbital and external disease","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"83300","49","TCOND","CDXC14","QDXC14","R14_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Profound bilateral imp., legal blindness","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.79",,,"0.55","1.09",,"4500","25","TCOND","CDXC8","QDXC8","R8_6","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal vein occlusion","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.03","0.05",,"448700","28","TCOND","CDXC4","QDXC4","R4_3","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","All Blindness and low vision","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.35",,,"0.26","0.46",,"14700","49","TCOND","CDXC8","QDXC8","R8_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","UT","Utah","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01","0","62300","49","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.31",,,"0.27","0.35",,"68500","27","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Myopic degeneration","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.03",,"457200","59","TCOND","CDXC4","QDXC4","R4_9","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT",
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.61",,,"0.57","0.65",,"143900","47","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","1.86",,,"1.34","2.5",,"2300","49","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.02","0","16900","54","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","0-17 years","Male","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"27","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGE017","GM","ALLRACE","RFHTDR","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","All Disorders of optic nerve and visual pathways","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.04","0.04",,"5574500","6","TCOND","CDXC11","QDXC11","R11_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.03","0.05",,"441000","26","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.1","0","100","28","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.09",,"102500","22","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Moderate/Severe non-proliferative diabetic retinopathy","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"40700","15","TCOND","CDXC2","QDXC2","R2_2","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Any diagnostic eye test","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","10.17",,,"8.04","12.64","100","700","46","TUTL","CTEST","QTEST","RTESTANY","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.52",,"700","53","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","All ages","All genders","All races","Hypertension and cataract","Yes","%","Crude Prevalence","24.7",,,"22.65","26.84","400","1700","29","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGEALL","GALL","ALLRACE","RFHTCAT","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"5574500","6","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.03",,"196600","28","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.53",,,"0.51","0.55",,"470800","42","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.55",,,"0.37","0.78","0","5500","29","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","US","National","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","40-64 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","9.58",,,"9.46","9.7","21000","219200","59","TUTL","CVC","QVC","RVCANY","CRDPREV","AGE4064","GM","ALLRACE","RFDM","RFYES",
"2014","2014","VT","Vermont","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Any cataract treatment","85 years and older","All genders","All races","Diabetes and cataract","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"50","TUTL","CCATS","QCATS","RCATANY","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFDMCAT","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","TN","Tennessee","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.27",,,"0.26","0.29",,"286800","47","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.05",,"76000","40","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.03","0.07","0","59000","29","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.08","0.16",,"26000","13","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","5.12",,,"4.96","5.27",,"77900","19","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.07","0.12",,"54400","40","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","5.67",,,"5.58","5.76",,"271100","29","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"336000","22","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.12",,"3000","22","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","IA","Iowa","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.07",,"59300","19","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","10.64",,,"10.51","10.78",,"200300","27","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.04","0.15",,"11500","42","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0","0.36",,"1500","56","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Severe stage","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.04","0.35",,"2900","26","TCOND","CDXC5","QDXC5","R5_XS","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","US","National","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","4.66",,,"4.64","4.67",,"13076400","59","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT",
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0","0.12",,"5800","19","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.29",,,"0.17","0.45",,"6600","41","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.29",,,"0.27","0.32",,"207600","42","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an optometrist or optician","85 years and older","Female","All races","Diabetes","Yes","%","Crude Prevalence","2.75",,,"1.19","5.34","0","300","42","TUTL","CUTLEX","QUTLEX","REXOPT","CRDPREV","AGE85PLUS","GF","ALLRACE","RFDM","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.64",,,"0.62","0.65",,"1051700","13","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Color blindness","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"42290900","59","TCOND","CDXC12","QDXC12","R12_2","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT",
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary angle-closure glaucoma","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"193300","27","TCOND","CDXC5","QDXC5","R5_5","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.07","0.1",,"295100","13","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.08",,"411500","13","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.54",,,"0.15","1.39",,"700","50","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","85 years and older","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"50","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFHTDR","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.06",,,"0.03","0.09","0","33400","27","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","3.71",,,"3.62","3.81",,"146000","9","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","65-84 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.08","0","4500","34","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGE6584","GALL","ALLRACE","RFHT","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","1.31",,,"0.53","2.68",,"500","49","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.05","0.08",,"129800","6","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.21",,,"0.16","0.27",,"29100","34","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.23","0","1600","50","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","40-64 years","Female","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","1.91",,,"1.31","2.69","0","1700","42","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGE4064","GF","ALLRACE","RFHTDR","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","AR","Arkansas","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"197800","5","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-92.2744907429996 34.7486501240004)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"242500","54","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0","0.39",,"1400","54","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","1.12",,,"1.09","1.16",,"424200","26","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.08",,"4600","56","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"193300","27","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.17",,,"0.14","0.2",,"98100","13","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0","0.18",,"3100","53","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Severe stage","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.4",,,"0.34","0.48",,"32600","27","TCOND","CDXC5","QDXC5","R5_XS","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","TN","Tennessee","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"28600","47","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"470800","42","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"5574500","6","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","8.28",,,"8.15","8.4",,"189500","39","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.07","0.09",,"406100","25","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2013","2013","AZ","Arizona","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.96",,,"0.93","0.98",,"687300","4","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.763811276999 34.8659702800004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an ophthalmologist or other physician","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","3.53",,,"2.14","5.46","0","500","29","TUTL","CUTLEX","QUTLEX","REXPHS","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","AZ","Arizona","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","All Disorders of optic nerve and visual pathways","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.27",,,"0.2","0.36",,"16700","4","TCOND","CDXC11","QDXC11","R11_ALL","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.763811276999 34.8659702800004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.08","0.09",,"1338500","42","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.02",,"176300","26","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.05","0.15",,"15200","16","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","AR","Arkansas","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.29",,,"0.27","0.3",,"398900","5","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.2744907429996 34.7486501240004)"
"2014","2014","UT","Utah","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Tonometry?test","65-84 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","5.69","0","100","49","TUTL","CTEST","QTEST","RTONO","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFYES","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03",,"116700","25","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Other Eye Disorders","Annual prevalence of treated other eye disorders","All Other eye disorders","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","1.29",,,"1.18","1.4",,"41300","54","TCOND","CDXC17","QDXC17","R17_ALL","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"331500","34","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.05","0.07",,"213800","49","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"868400","34","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","0-17 years","Male","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"27","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE017","GM","ALLRACE","RFDR","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Any vision screening","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","12.98",,,"12.92","13.05","135600","1045000","22","TUTL","CSCRN","QSCRN","RSCNANY","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Early/mild diabetic retinopathy","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.52",,"700","53","TCOND","CDXC2","QDXC2","R2_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"470800","42","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.28",,"1300","15","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","85 years and older","Male","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"50","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE85PLUS","GM","ALLRACE","RFHTAMD","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"784700","13","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","0-17 years","All genders","All races","Glaucoma","Yes","%","Crude Prevalence","1.65",,,"1.01","2.54","0","1200","42","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE017","GALL","ALLRACE","RFGLC","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Other Eye Disorders","Annual prevalence of treated other eye disorders","All Other eye disorders","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.66",,,"1.47","1.88",,"15400","49","TCOND","CDXC17","QDXC17","R17_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Any diagnostic eye test","0-17 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","2.97",,,"1.87","4.46","0","700","28","TUTL","CTEST","QTEST","RTESTANY","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an optometrist or optician","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","12.9",,,"8.06","19.22","0","200","56","TUTL","CUTLEX","QUTLEX","REXOPT","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal arterial occlusion","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.05",,"10500","53","TCOND","CDXC4","QDXC4","R4_4","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","0.18",,,"0.14","0.22","100","46800","42","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","WY","Wyoming","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"52200","56","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.11",,,"0.1","0.11",,"1078800","39","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2013","2013","VT","Vermont","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.51",,"700","50","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Lacrimal diseases","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"263100","40","TCOND","CDXC14","QDXC14","R14_3","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.42",,,"0.37","0.48",,"54100","22","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","85 years and older","All genders","All races","Glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"28","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFGLC","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","All ages","Female","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","13.14",,,"12.05","14.28","500","3600","42","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGEALL","GF","ALLRACE","RFDMDR","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","40-64 years","Male","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","2.44",,,"1.3","4.13","0","500","27","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGE4064","GM","ALLRACE","RFHTDR","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","MI","Michigan","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","40-64 years","All genders","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence","5.45",,,"4.77","6.19","200","4100","26","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE4064","GALL","ALLRACE","RFDMGLC","RFYES","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","65-84 years","All genders","All races","Diabetic retinopathy","Yes","%","Crude Prevalence","0",,,"0","6.06","0","100","22","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGE6584","GALL","ALLRACE","RFDR","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Non-Occlusive retinal vascular disease","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.03","0.05",,"132900","27","TCOND","CDXC4","QDXC4","R4_6","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","0-17 years","All genders","All races","Glaucoma","Yes","%","Crude Prevalence","0.69",,,"0.36","1.2","0","1700","22","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE017","GALL","ALLRACE","RFGLC","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.22",,"1700","49","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Other/unspecified infectious and inflammatory diseases","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.13",,,"0.12","0.14",,"474300","42","TCOND","CDXC13","QDXC13","R13_5","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.03","0","14500","42","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","LA","Louisiana","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","10.93",,,"10.68","11.19",,"56900","22","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","AR","Arkansas","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","7.48",,,"7.1","7.87",,"18300","5","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-92.2744907429996 34.7486501240004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.73",,,"0.69","0.77",,"169000","28","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"342400","47","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.45",,,"0.43","0.47",,"343600","59","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT",
"2014","2014","UT","Utah","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Glaucoma screening","18-39 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.26","0","1400","49","TUTL","CSCRN","QSCRN","RSCNGLA","CRDPREV","AGE1839","GALL","ALLRACE","RFDM","RFYES","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","CA","California","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0.04",,,"0.01","0.13","0","7000","6","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","ID","Idaho","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","All ages","Female","All races","Diabetes","Yes","%","Crude Prevalence","8.35",,,"7.42","9.35","300","3300","16","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGEALL","GF","ALLRACE","RFDM","RFYES","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"254400","53","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2013","2013","AR","Arkansas","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.15",,,"0.14","0.16",,"729500","5","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.2744907429996 34.7486501240004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.05","0.07",,"570800","34","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Lacrimal diseases","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.21",,,"0.2","0.22",,"1078800","39","TCOND","CDXC14","QDXC14","R14_3","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2013","2013","IN","Indiana","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Unspecified-age related macular degeneration","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","1.1",,,"0.94","1.27",,"16400","18","TCOND","CDXC3","QDXC3","R3_1","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-86.1499601939996 39.7669104520004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.26",,,"0.24","0.29",,"146400","13","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular burns","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03",,"50400","54","TCOND","CDXC10","QDXC10","R10_2","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.04",,"29900","49","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.09","0.15",,"68500","27","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","All ages","All genders","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","4.41",,,"0.92","12.36","0","100","56","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGEALL","GALL","ALLRACE","RFDMDR","RFYES","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.02","0.13",,"10200","49","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Keratitis","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.41",,,"0.27","0.6",,"6600","41","TCOND","CDXC13","QDXC13","R13_2","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"4302600","6","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.53",,,"0.49","0.58",,"105000","54","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an ophthalmologist or other physician","65-84 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","16.84",,,"13.24","20.95","100","400","13","TUTL","CUTLEX","QUTLEX","REXPHS","CRDPREV","AGE6584","GM","ALLRACE","RFDM","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"22","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","All Disorders of optic nerve and visual pathways","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.21",,,"0.2","0.22",,"862500","6","TCOND","CDXC11","QDXC11","R11_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.31",,,"1.24","1.39",,"84600","15","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2013","2013","WY","Wyoming","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.5",,,"0.32","0.74",,"4800","56","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.03",,"51300","50","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","All ages","Male","All races","Cataract","Yes","%","Crude Prevalence","20.41",,,"18.79","22.1","500","2300","47","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGEALL","GM","ALLRACE","RFCAT","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0","0.42",,"1300","15","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Endothelial dystrophy (Fuchs)","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.01","0.07",,"18000","16","TCOND","CDXC16","QDXC16","R16_2","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.24",,,"0.19","0.3",,"29000","9","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","40-64 years","Male","All races","Glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"56","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGE4064","GM","ALLRACE","RFGLC","RFYES","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.03",,"26000","13","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.93","0","400","56","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal vein occlusion","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.05",,"66000","22","TCOND","CDXC4","QDXC4","R4_3","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","4.81",,,"4.65","4.98",,"66500","41","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","All Injury, burns and surgical complications of the eye","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.18",,,"0.17","0.18",,"4486200","6","TCOND","CDXC10","QDXC10","R10_ALL","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.02","0.17",,"7000","46","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","All ages","All genders","All races","Diabetic retinopathy","Yes","%","Crude Prevalence","13.71",,,"12.1","15.45","200","1700","28","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGEALL","GALL","ALLRACE","RFDR","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Glaucoma screening","0-17 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.33","0","300","46","TUTL","CSCRN","QSCRN","RSCNGLA","CRDPREV","AGE017","GF","ALLRACE","RFDM","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","NY","New York","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate imp. better eye, profound imp. lesser eye","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.04","0.05",,"533800","36","TCOND","CDXC8","QDXC8","R8_4","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-75.5439704269996 42.8270010320004)"
"2014","2014","UT","Utah","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","0-17 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","11.49",,,"7.16","17.19","0","200","49","TUTL","CVC","QVC","RGLASS","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFYES","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Congenital Cataract","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.2",,,"0.17","0.23",,"85600","13","TCOND","CDXC6","QDXC6","R6_3","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","85 years and older","Female","All races","Hypertension","Yes","%","Crude Prevalence","32.86",,,"22.09","45.12","0","100","27","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE85PLUS","GF","ALLRACE","RFHT","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","9.81",,,"9.65","9.97",,"132800","28","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.97",,,"0.95","1",,"445800","28","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0","0.14",,"5100","56","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.06","0.07",,"959400","42","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an ophthalmologist or other physician","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","7.64",,,"6.1","9.42","100","1000","46","TUTL","CUTLEX","QUTLEX","REXPHS","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment, both eyes","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0","0.18",,"3000","56","TCOND","CDXC8","QDXC8","R8_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal arterial occlusion","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"42290900","59","TCOND","CDXC4","QDXC4","R4_4","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT",
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.6",,,"0.5","0.72",,"20900","56","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment, both eyes","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.03",,"45200","19","TCOND","CDXC8","QDXC8","R8_1","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","3.81",,,"3.16","4.56",,"3000","46","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","All Age-related macular degeneration (AMD)","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.54",,,"0.53","0.55",,"1176700","27","TCOND","CDXC3","QDXC3","R3_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","1.05",,,"1.02","1.09",,"332700","34","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.1",,,"0.03","0.26",,"4000","46","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Early/mild diabetic retinopathy","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","1.79",,,"1.68","1.91",,"52800","25","TCOND","CDXC2","QDXC2","R2_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"929200","42","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","MI","Michigan","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","40-64 years","All genders","All races","Hypertension and AMD","Yes","%","Crude Prevalence","0.72",,,"0.15","2.1","0","400","26","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE4064","GALL","ALLRACE","RFHTAMD","RFYES","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.11",,"3300","46","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.28",,,"0.22","0.35",,"28300","27","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Visual pathway disorders","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"394000","26","TCOND","CDXC11","QDXC11","R11_2","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","WY","Wyoming","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"52200","56","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0","0.18",,"3200","16","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","All Other visual disturbances","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.73",,,"1.51","1.98",,"12600","46","TCOND","CDXC12","QDXC12","R12_ALL","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","MI","Michigan","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","1040800","26","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"103600","49","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.28",,,"0.23","0.33",,"44700","29","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","32.7",,,"31.7","33.72","2700","8300","28","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.15",,,"0.13","0.17",,"128400","13","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.05","0.09",,"63000","28","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","MO","Missouri","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","1.71",,,"1.61","1.81",,"69900","29","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","1.35",,,"1.34","1.35",,"29815300","59","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT",
"2013","2013","VT","Vermont","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.2",,,"0.07","0.43",,"3000","50","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","ID","Idaho","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Contact lens or fitting","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.03","0.04","100","273300","16","TUTL","CVC","QVC","RCONTAC","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","3.69",,,"3.41","4","600","15900","13","TUTL","CVC","QVC","RVCANY","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Endothelial dystrophy (Fuchs)","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.1",,,"0.05","0.18",,"11700","16","TCOND","CDXC16","QDXC16","R16_2","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","85 years and older","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"46","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFHTDR","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an optometrist or optician","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","3.57",,,"3.52","3.62","17800","498900","42","TUTL","CUTLEX","QUTLEX","REXOPT","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"28","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.38",,,"0.32","0.44",,"37800","15","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate imp. better eye, profound imp. lesser eye","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02",,"45200","19","TCOND","CDXC8","QDXC8","R8_4","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.02",,"22600","56","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","Retinal detachment and defects","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.03",,"27500","47","TCOND","CDXC1","QDXC1","R1_1","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","US","National","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.29",,,"0.28","0.29",,"4259100","59","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT",
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Moderate/Severe non-proliferative diabetic retinopathy","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"142900","25","TCOND","CDXC2","QDXC2","R2_2","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.07","0.12",,"45500","50","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.95",,,"0.74","1.21",,"7200","16","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.13","0.16",,"282600","41","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.2",,,"0.16","0.25",,"38200","39","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","65-84 years","Female","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","14.93",,,"9.36","22.11","0","100","27","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE6584","GF","ALLRACE","RFDMDR","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Vision screening","0-17 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","19.19",,,"16.97","21.57","200","1200","47","TUTL","CSCRN","QSCRN","RSCNVIS","CRDPREV","AGE017","GALL","ALLRACE","RFHT","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"432500","54","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","1.53",,,"1.34","1.75",,"14500","28","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.03",,"28900","46","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Conjunctivitis","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","2.88",,,"2.41","3.41",,"4500","46","TCOND","CDXC13","QDXC13","R13_3","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","SD","South Dakota","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","All ages","All genders","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","8.64",,,"5.28","13.16","0","200","46","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGEALL","GALL","ALLRACE","RFDMDR","RFYES","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.23",,,"0.22","0.24",,"670200","34","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","1.31",,,"1.23","1.4",,"66000","22","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.67","0","200","19","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","1.05",,,"0.96","1.15",,"47500","39","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Severe stage","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0","0.07",,"9700","46","TCOND","CDXC5","QDXC5","R5_XS","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","MO","Missouri","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Proliferative diabetic retinopathy","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.4",,,"0.35","0.46",,"47200","29","TCOND","CDXC2","QDXC2","R2_3","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Moderate bilateral impairment","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.04",,"54100","22","TCOND","CDXC8","QDXC8","R8_5","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.66",,,"0.5","0.85",,"8700","41","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.83",,,"0.79","0.87",,"191800","13","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.25",,,"0.21","0.3",,"54100","22","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Other/unspecified other retinal disorders","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.09","0.15",,"65100","49","TCOND","CDXC4","QDXC4","R4_10","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","2.75",,,"2.71","2.8",,"498900","42","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","8.92",,,"8.57","9.29",,"24700","50","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","All Orbital and external disease","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","1.42",,,"1.27","1.57",,"24900","34","TCOND","CDXC14","QDXC14","R14_ALL","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.13",,,"0.11","0.15",,"215900","27","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","AZ","Arizona","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.17",,,"0.16","0.19",,"337500","4","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-111.763811276999 34.8659702800004)"
"2014","2014","IA","Iowa","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.59",,,"0.56","0.62",,"287800","19","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Strabismus","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.61",,,"0.59","0.63",,"567800","13","TCOND","CDXC9","QDXC9","R9_1","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By an ophthalmologist or other physician","All ages","Female","All races","Hypertension","Yes","%","Crude Prevalence","11.33",,,"10.97","11.7","3300","29400","22","TUTL","CUTLEX","QUTLEX","REXPHS","CRDPREV","AGEALL","GF","ALLRACE","RFHT","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"60000","22","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","NJ","New Jersey","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Other refraction and accommodation disorders","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.01","0.06",,"29100","34","TCOND","CDXC7","QDXC7","R7_5","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Optic nerve disorders","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.18",,,"0.17","0.19",,"1107500","29","TCOND","CDXC11","QDXC11","R11_1","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","MI","Michigan","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","18.98",,,"17.07","21.01","300","1600","26","TUTL","CVC","QVC","RGLASS","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","All Disorders of optic nerve and visual pathways","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.42",,,"0.37","0.48",,"54100","22","TCOND","CDXC11","QDXC11","R11_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","All Infectious and inflammatory diseases","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","3.71",,,"3.66","3.77",,"423000","26","TCOND","CDXC13","QDXC13","R13_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Lacrimal and orbit inflammation","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.08","0.09",,"597900","47","TCOND","CDXC13","QDXC13","R13_6","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0.16","0.22",,"90400","54","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Other Eye Disorders","Annual prevalence of treated other eye disorders","All Other eye disorders","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.48",,,"0.44","0.54",,"76000","40","TCOND","CDXC17","QDXC17","R17_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","All Infectious and inflammatory diseases","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","5.52",,,"5.49","5.55",,"2133000","6","TCOND","CDXC13","QDXC13","R13_ALL","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Visual field defect","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.11",,,"0.11","0.12",,"1151700","26","TCOND","CDXC12","QDXC12","R12_1","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","WY","Wyoming","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.84",,,"0.17","2.44",,"400","56","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","CA","California","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","18-39 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.02","0","18300","6","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE1839","GM","ALLRACE","RFHT","RFYES","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","TN","Tennessee","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Senile cataract","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.17",,,"0.13","0.23",,"28600","47","TCOND","CDXC6","QDXC6","R6_1","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","18-39 years","Male","All races","Hypertension and glaucoma","Yes","%","Crude Prevalence","4.11",,,"0.86","11.54","0","100","42","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE1839","GM","ALLRACE","RFHTGLC","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.04",,"110600","25","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","0-17 years","All genders","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"34","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE017","GALL","ALLRACE","RFDMGLC","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Low-tension glaucoma","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.03","0.05",,"207600","42","TCOND","CDXC5","QDXC5","R5_3","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.19",,,"0.07","0.4",,"3200","28","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","18-39 years","Male","All races","Diabetes and cataract","Yes","%","Crude Prevalence","50",,,"21.09","78.91","0","0","19","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE1839","GM","ALLRACE","RFDMCAT","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","0-17 years","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"50","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE017","GALL","ALLRACE","RFHTDR","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","OH","Ohio","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","1.4",,,"1.36","1.43",,"445800","39","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-82.4042600559996 40.0602101410004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.02",,"22300","47","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","6.11",,,"5.55","6.7",,"6900","15","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2013","2013","NY","New York","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","All ages","Male","All races","All patients","Total","%","Crude Prevalence","2.51",,,"2.49","2.53",,"2654600","36","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-75.5439704269996 42.8270010320004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","All ages","All genders","All races","Hypertension and glaucoma","Yes","%","Crude Prevalence","0.84",,,"0.6","1.16","0","4500","34","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGEALL","GALL","ALLRACE","RFHTGLC","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Early/mild diabetic retinopathy","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.02","0.02",,"3258700","6","TCOND","CDXC2","QDXC2","R2_1","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"45500","50","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","CA","California","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02","0","147800","6","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","85 years and older","Female","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"27","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE85PLUS","GF","ALLRACE","RFDR","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","CA","California","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","40-64 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","0.02",,,"0.02","0.03","0","156700","6","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE4064","GF","ALLRACE","RFHT","RFYES","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","18-39 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.25","0","1500","29","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGE1839","GM","ALLRACE","RFDM","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","All ages","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0.27",,,"0.13","0.48","0","4100","50","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGEALL","GALL","ALLRACE","RFHT","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","UT","Utah","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","65-84 years","All genders","All races","Age-related macular degeneration","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"49","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE6584","GALL","ALLRACE","RFAMD","RFYES","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.03",,"199100","28","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03",,"104500","19","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Early/mild diabetic retinopathy","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.37",,,"0.32","0.43",,"49800","6","TCOND","CDXC2","QDXC2","R2_1","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Disorders of Optic Nerve and Visual Pathways","Annual prevalence of treated disorders of optic nerve and visual pathways","Visual pathway disorders","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.04",,"10500","53","TCOND","CDXC11","QDXC11","R11_2","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Dry-form age-related macular degeneration","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.07",,,"0.07","0.08",,"4441800","6","TCOND","CDXC3","QDXC3","R3_3","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","18-39 years","Female","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"34","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE1839","GF","ALLRACE","RFHTAMD","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"455000","29","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Endophthalmitis","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.04",,"83400","19","TCOND","CDXC13","QDXC13","R13_7","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.58",,,"0.27","1.11",,"1500","56","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","18-39 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.06","0.06",,"5574500","6","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE1839","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Other/unspecified visual disturbances","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.07","0.09",,"1018200","22","TCOND","CDXC12","QDXC12","R12_4","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","All Glaucoma","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.07","0.1",,"115200","49","TCOND","CDXC5","QDXC5","R5_ALL","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","AZ","Arizona","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Keratoconus","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.07",,"100500","4","TCOND","CDXC16","QDXC16","R16_1","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-111.763811276999 34.8659702800004)"
"2014","2014","MI","Michigan","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","All ages","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","0.01","0","69600","26","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGEALL","GALL","ALLRACE","RFDM","RFYES","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","18-39 years","All genders","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"42","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE1839","GALL","ALLRACE","RFHTAMD","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Retinal Detachment and Defects","Annual prevalence of treated retinal detachment and defects","Retinal detachment and defects","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.04","0.27",,"4300","16","TCOND","CDXC1","QDXC1","R1_1","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","85 years and older","Female","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","3.93","0","100","13","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGE85PLUS","GF","ALLRACE","RFDM","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Dry eye syndrome","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","1.1",,,"1.08","1.12",,"919100","25","TCOND","CDXC14","QDXC14","R14_5","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2013","2013","WA","Washington","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.94",,,"0.92","0.96",,"948900","53","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-120.470010789999 47.5222786290004)"
"2013","2013","TN","Tennessee","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Proliferative diabetic retinopathy","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"370300","47","TCOND","CDXC2","QDXC2","R2_3","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","All Blindness and low vision","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.25",,,"0.2","0.3",,"39500","54","TCOND","CDXC8","QDXC8","R8_ALL","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","2.05",,,"1.73","2.41",,"7000","46","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Pseudophakia","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.26",,,"0.22","0.31",,"52300","41","TCOND","CDXC6","QDXC6","R6_5","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Other Eye Disorders","Annual prevalence of treated other eye disorders","All Other eye disorders","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.85",,,"0.55","1.26",,"2800","26","TCOND","CDXC17","QDXC17","R17_ALL","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","US","National","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","65-84 years","Male","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence","17.62",,,"15.93","19.41","300","1900","59","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE6584","GM","ALLRACE","RFDMDR","RFYES",
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.12","0.15",,"246100","26","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","CA","California","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Victrectomy","85 years and older","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","2.86",,,"0.59","8.12","0","100","6","TUTL","CDRTX","QDRTX","RDRVIC","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFHTDR","RFYES","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Color blindness","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"755200","34","TCOND","CDXC12","QDXC12","R12_2","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","IA","Iowa","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Branch retinal artery occlusion","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.02","0.12",,"12300","19","TCOND","CDXC4","QDXC4","R4_5","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Posterior capsular opacity","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.26",,,"0.22","0.31",,"59900","46","TCOND","CDXC6","QDXC6","R6_4","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","ID","Idaho","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","65-84 years","Male","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"16","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE6584","GM","ALLRACE","RFDMDR","RFYES","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","65-84 years","Male","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"13","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE6584","GM","ALLRACE","RFDR","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.51",,,"0.39","0.66",,"11500","42","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","All Refraction and accommodation disorders","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","3.84",,,"3.73","3.96",,"110400","54","TCOND","CDXC7","QDXC7","R7_ALL","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","40-64 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","3.69",,,"2.16","5.84","0","500","56","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGE4064","GALL","ALLRACE","RFHT","RFYES","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.83",,,"0.65","1.05",,"8400","56","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","US","National","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","85 years and older","Male","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence","9.52",,,"4.2","17.91","0","100","59","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE85PLUS","GM","ALLRACE","RFDMGLC","RFYES",
"2014","2014","US","National","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Contact lens or fitting","0-17 years","Male","All races","Diabetes","Yes","%","Crude Prevalence","0.34",,,"0.24","0.46","0","11900","59","TUTL","CVC","QVC","RCONTAC","CRDPREV","AGE017","GM","ALLRACE","RFDM","RFYES",
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.41",,,"0.38","0.44",,"242500","26","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Myopic degeneration","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.05",,"21900","50","TCOND","CDXC4","QDXC4","R4_9","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Drain","0-17 years","Female","All races","Glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"29","TUTL","CGLAUTX","QGLAU","RGLADRN","CRDPREV","AGE017","GF","ALLRACE","RFGLC","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","1.12",,,"0.94","1.31",,"13000","40","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2013","2013","PA","Pennsylvania","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Conjunctivitis","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","4.05",,,"4.01","4.08",,"1026100","42","TCOND","CDXC13","QDXC13","R13_3","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Non-Occlusive retinal vascular disease","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.09","0.1",,"1072200","27","TCOND","CDXC4","QDXC4","R4_6","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","ID","Idaho","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.07","0.09",,"174500","16","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.31",,,"0.24","0.41",,"18200","28","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.26",,,"0.22","0.31","200","57000","54","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Myopic degeneration","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.04",,"14100","22","TCOND","CDXC4","QDXC4","R4_9","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Congenital anomalies","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.11","0.14",,"267300","27","TCOND","CDXC14","QDXC14","R14_1","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Glaucoma surgery","40-64 years","Female","All races","Hypertension and glaucoma","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"56","TUTL","CGLAUTX","QGLAU","RGLASUR","CRDPREV","AGE4064","GF","ALLRACE","RFHTGLC","RFYES","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","TN","Tennessee","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.04","0.08",,"82600","47","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","MI","Michigan","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.54",,,"0.51","0.57",,"242500","26","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Other/unspecified infectious and inflammatory diseases","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.22",,,"0.19","0.26",,"75200","40","TCOND","CDXC13","QDXC13","R13_5","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2013","2013","LA","Louisiana","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.18",,"2000","22","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Early stage age-related macular degeneration","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.03",,"1055400","13","TCOND","CDXC3","QDXC3","R3_2","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Contact lens or fitting","65-84 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"29","TUTL","CVC","QVC","RCONTAC","CRDPREV","AGE6584","GALL","ALLRACE","RFDM","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Other Eye Disorders","Annual prevalence of treated other eye disorders","All Other eye disorders","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","1.99",,,"1.32","2.86",,"1400","54","TCOND","CDXC17","QDXC17","R17_ALL","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Tonometry?test","85 years and older","Female","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"22","TUTL","CTEST","QTEST","RTONO","CRDPREV","AGE85PLUS","GF","ALLRACE","RFHT","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Any diagnostic eye test","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","1.48",,,"1.32","1.65","300","20900","56","TUTL","CTEST","QTEST","RTESTANY","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","MS","Mississippi","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.58",,,"0.52","0.64",,"63000","28","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Diabetic macular edema","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.03","0.22",,"5300","46","TCOND","CDXC2","QDXC2","R2_4","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","MS","Mississippi","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","65-84 years","Female","All races","Hypertension","Yes","%","Crude Prevalence","1.42",,,"0.46","3.27","0","400","28","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGE6584","GF","ALLRACE","RFHT","RFYES","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Endothelial dystrophy (Fuchs)","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.55",,,"0.42","0.71",,"10800","15","TCOND","CDXC16","QDXC16","R16_2","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Anti-VEGF injections","65-84 years","All genders","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"19","TUTL","CAMDTX","QAMD","RVEGF","CRDPREV","AGE6584","GALL","ALLRACE","RFHTAMD","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Macular edema (not diabetic)","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"215400","29","TCOND","CDXC4","QDXC4","R4_7","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","ID","Idaho","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Any age related macular degeneration treatment","65-84 years","Female","All races","Diabetes and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"16","TUTL","CAMDTX","QAMD","RAMDANY","CRDPREV","AGE6584","GF","ALLRACE","RFDMAMD","RFYES","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Anti-VEGF injections","85 years and older","All genders","All races","Diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"22","TUTL","CDRTX","QDRTX","RVEGF","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFDR","RFYES","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","65-84 years","All genders","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence","11.83",,,"6.05","20.18","0","100","13","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE6584","GALL","ALLRACE","RFHTDR","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","40-64 years","All genders","All races","Age-related macular degeneration","Yes","%","Crude Prevalence","0",,,"0","0.72","0","500","27","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE4064","GALL","ALLRACE","RFAMD","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","AR","Arkansas","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","1.74",,,"1.61","1.88",,"35700","5","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-92.2744907429996 34.7486501240004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Conjunctivitis","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","3.04",,,"2.4","3.79",,"2500","40","TCOND","CDXC13","QDXC13","R13_3","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2013","2013","NY","New York","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.11","0.14",,"199800","36","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-75.5439704269996 42.8270010320004)"
"2014","2014","CA","California","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Contact lens or fitting","85 years and older","All genders","All races","Hypertension","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"6","TUTL","CVC","QVC","RCONTAC","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFHT","RFYES","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Laser surgery","40-64 years","All genders","All races","Hypertension and AMD","Yes","%","Crude Prevalence","0",,,"0","2.93","0","100","27","TUTL","CAMDTX","QAMD","RLASER","CRDPREV","AGE4064","GALL","ALLRACE","RFHTAMD","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Any diabetic retinopathy treatment","65-84 years","Male","All races","Diabetes and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"19","TUTL","CDRTX","QDRTX","RDRANY","CRDPREV","AGE6584","GM","ALLRACE","RFDMDR","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","IA","Iowa","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Laser/photocoagulation","65-84 years","Male","All races","Hypertension and diabetic retinopathy","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"19","TUTL","CDRTX","QDRTX","RLASPH","CRDPREV","AGE6584","GM","ALLRACE","RFHTDR","RFYES","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Narrow-angle glaucoma","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03",,"106500","46","TCOND","CDXC5","QDXC5","R5_6","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","AR","Arkansas","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Primary open-angle glaucoma","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.01",,"398900","5","TCOND","CDXC5","QDXC5","R5_2","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.2744907429996 34.7486501240004)"
"2013","2013","MO","Missouri","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Severe stage","18-39 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.01",,"70900","29","TCOND","CDXC5","QDXC5","R5_XS","CRDPREV","AGE1839","GM","ALLRACE","RFALL","RFTOT","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","MN","Minnesota","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Vision impairment one eye","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.04","0.07",,"119700","27","TCOND","CDXC8","QDXC8","R8_3","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","UT","Utah","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Any diagnostic eye test","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","1.29",,,"1.11","1.49","200","13700","49","TUTL","CTEST","QTEST","RTESTANY","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Endophthalmitis","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0.05","0.06",,"3258700","6","TCOND","CDXC13","QDXC13","R13_7","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.24",,,"0.12","0.42",,"4600","19","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","IA","Iowa","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.67",,,"0.53","0.83",,"12100","19","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Glaucoma screening","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0","0","2014000","42","TUTL","CSCRN","QSCRN","RSCNGLA","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","PA","Pennsylvania","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0.66",,,"0.64","0.68",,"498900","42","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Severe stage","0-17 years","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0",,"96200","54","TCOND","CDXC5","QDXC5","R5_XS","CRDPREV","AGE017","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","18-39 years","All genders","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence","3.33",,,"0.92","8.31","0","100","27","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE1839","GALL","ALLRACE","RFDMGLC","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Eyelid disorders","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.05",,,"0","0.26",,"2100","22","TCOND","CDXC14","QDXC14","R14_4","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Severe stage","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.24",,,"0.21","0.27",,"104500","28","TCOND","CDXC5","QDXC5","R5_XS","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
"2013","2013","GA","Georgia","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Congenital glaucoma","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"73900","13","TCOND","CDXC5","QDXC5","R5_7","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.01","0.42",,"1700","49","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","CA","California","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.25",,,"0.24","0.26",,"1303400","6","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.98",,,"0.83","1.14",,"15400","49","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.05","0.06","700","1134900","47","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.2",,,"0.1","0.37",,"5000","49","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Contact lens or fitting","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","1",,,"0.9","1.11","300","33000","42","TUTL","CVC","QVC","RCONTAC","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","Amblyopia","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.17",,"2100","22","TCOND","CDXC9","QDXC9","R9_2","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.09",,,"0.03","0.19",,"7000","46","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","NJ","New Jersey","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Laser surgery","65-84 years","All genders","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence","14.39",,,"11.21","18.06","100","400","34","TUTL","CGLAUTX","QGLAU","RLASER","CRDPREV","AGE6584","GALL","ALLRACE","RFDMGLC","RFYES","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Strabismus and Amblyopia","Annual prevalence of treated strabismus and amblyopia","All Strabismus and amblyopia","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","2.54",,,"2.48","2.6",,"285900","9","TCOND","CDXC9","QDXC9","R9_ALL","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2014","2014","WY","Wyoming","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Laser surgery","All ages","Female","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"56","TUTL","CAMDTX","QAMD","RLASER","CRDPREV","AGEALL","GF","ALLRACE","RFHTAMD","RFYES","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0","0.04",,"25200","54","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2013","2013","CT","Connecticut","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Lacrimal and orbit inflammation","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.55",,,"0.54","0.57",,"772400","9","TCOND","CDXC13","QDXC13","R13_6","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Hereditary chorioretinal dystrophy","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0","0.05",,"16900","46","TCOND","CDXC4","QDXC4","R4_8","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Diagnosed Blindness and Low Vision","Annual prevalence of treated blindness and low vision","Unqualified impairment in one eye, or unspecified","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.34",,,"0.32","0.36",,"332700","34","TCOND","CDXC8","QDXC8","R8_2","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2013","2013","MA","Massachusetts","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Myopia","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","2.12",,,"1.92","2.34",,"18600","25","TCOND","CDXC7","QDXC7","R7_1","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.0826906749996 42.2768704700004)"
"2014","2014","WY","Wyoming","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","All Other retinal disorders","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.08","0.17",,"22600","56","TCOND","CDXC4","QDXC4","R4_ALL","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","WY","Wyoming","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Other refraction and accommodation disorders","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.32",,,"0.26","0.4",,"26900","56","TCOND","CDXC7","QDXC7","R7_5","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","7.13",,,"6.81","7.45",,"25000","15","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","LA","Louisiana","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Any vision correction","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.28","0","1300","22","TUTL","CVC","QVC","RVCANY","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Vision Correction","Percentage of people who had a vision correction visit or supplies claim","Eyeglasses","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","13.79",,,"13.2","14.41","1700","12600","29","TUTL","CVC","QVC","RGLASS","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Neovascular glaucoma","0-17 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0.01","0.02",,"345300","22","TCOND","CDXC5","QDXC5","R5_8","CRDPREV","AGE017","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","UT","Utah","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Infectious diseases","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.39",,,"0.36","0.42",,"178700","49","TCOND","CDXC13","QDXC13","R13_1","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Conjunctivitis","0-17 years","All genders","All races","All patients","Total","%","Crude Prevalence","5.62",,,"5.56","5.67",,"668800","47","TCOND","CDXC13","QDXC13","R13_3","CRDPREV","AGE017","GALL","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","AR","Arkansas","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Central retinal vein occlusion","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.04",,,"0.03","0.05",,"89400","5","TCOND","CDXC4","QDXC4","R4_2","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.2744907429996 34.7486501240004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Lacrimal and orbit inflammation","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.12",,,"0.11","0.14",,"205400","13","TCOND","CDXC13","QDXC13","R13_6","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","CA","California","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Eyelid infection and inflammation","85 years and older","Female","All races","All patients","Total","%","Crude Prevalence","0.63",,,"0.58","0.67",,"115600","6","TCOND","CDXC13","QDXC13","R13_4","CRDPREV","AGE85PLUS","GF","ALLRACE","RFALL","RFTOT","POINT(-120.999999537999 37.6386401230004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Astigmatism","All ages","Male","All races","All patients","Total","%","Crude Prevalence","2.02",,,"1.97","2.08",,"282600","41","TCOND","CDXC7","QDXC7","R7_3","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2013","2013","OR","Oregon","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.1",,,"0.01","0.34",,"2100","41","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-120.155031325999 44.5674494240004)"
"2014","2014","WV","West Virginia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Flourescein angiography","0-17 years","All genders","All races","Diabetes","Yes","%","Crude Prevalence","0",,,"0","1.95","0","200","54","TUTL","CTEST","QTEST","RANGIO","CRDPREV","AGE017","GALL","ALLRACE","RFDM","RFYES","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Infectious and Inflammatory Diseases","Annual prevalence of treated infectious and inflammatory diseases","Keratitis","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.16",,,"0.1","0.24",,"14100","22","TCOND","CDXC13","QDXC13","R13_2","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","WY","Wyoming","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.08",,,"0.02","0.24",,"3600","56","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-108.109830352999 43.2355413430004)"
"2014","2014","US","National","MAX","Service Utilization","Treatment for diabetic retinopathy","Percentage of people with diagnosed DR who had a treatment claim","Retinal detachment repair","All ages","Female","All races","Diabetic retinopathy","Yes","%","Crude Prevalence","1.81",,,"1.69","1.94","800","43100","59","TUTL","CDRTX","QDRTX","RDRRET","CRDPREV","AGEALL","GF","ALLRACE","RFDR","RFYES",
"2014","2014","MN","Minnesota","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.24",,,"0.23","0.25",,"649900","27","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-94.7942005029996 46.3556487360004)"
"2013","2013","SD","South Dakota","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","Other diabetes related eye disorders","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.09","0.21",,"16900","46","TCOND","CDXC2","QDXC2","R2_5","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Treatment for glaucoma","Percentage of people with diagnosed glaucoma who had treatment claim","Any glaucoma treatment","40-64 years","Female","All races","Diabetes and glaucoma","Yes","%","Crude Prevalence","10.17",,,"8.94","11.5","200","2200","42","TUTL","CGLAUTX","QGLAU","RGLAANY","CRDPREV","AGE4064","GF","ALLRACE","RFDMGLC","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2013","2013","AR","Arkansas","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Aphakia and disorders of lens","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.2",,,"0.17","0.25",,"54000","5","TCOND","CDXC6","QDXC6","R6_6","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT","POINT(-92.2744907429996 34.7486501240004)"
"2014","2014","WV","West Virginia","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.27",,,"0.19","0.36",,"14300","54","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Presbyopia","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.15",,,"0.14","0.16",,"450900","22","TCOND","CDXC7","QDXC7","R7_4","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2013","2013","WV","West Virginia","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Glaucoma suspect","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","1.91",,,"1.79","2.03",,"50400","54","TCOND","CDXC5","QDXC5","R5_4","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-80.7126401349996 38.6655102020004)"
"2014","2014","PA","Pennsylvania","MAX","Service Utilization","Screening","Percentage of people who had a vision or eye disease screening claim","Diabetic Retinopathy Telemedicine Screening","65-84 years","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.21","0","1700","42","TUTL","CSCRN","QSCRN","RSCNDR","CRDPREV","AGE6584","GM","ALLRACE","RFHT","RFYES","POINT(-77.8607002939996 40.7937301520004)"
"2014","2014","IA","Iowa","MAX","Eye Health Conditions","Other Retinal Disorders","Annual prevalence of treated other retinal disorders","Occlusive retinal vascular disease","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.05",,"44300","19","TCOND","CDXC4","QDXC4","R4_1","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-93.8164905559996 42.4694009130004)"
"2013","2013","HI","Hawaii","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Surgical complication of the eye","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.03",,,"0.02","0.06",,"37800","15","TCOND","CDXC10","QDXC10","R10_3","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-157.857749402999 21.3048504350004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Visual field testing","All ages","Male","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.02","0","15900","13","TUTL","CTEST","QTEST","RVISFLD","CRDPREV","AGEALL","GM","ALLRACE","RFHT","RFYES","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","US","National","MAX","Eye Health Conditions","Other Visual Disturbances","Annual prevalence of treated other visual disturbances","Night blindness","65-84 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.83",,,"0.81","0.84",,"1798200","59","TCOND","CDXC12","QDXC12","R12_3","CRDPREV","AGE6584","GALL","ALLRACE","RFALL","RFTOT",
"2013","2013","NJ","New Jersey","MAX","Eye Health Conditions","Diabetic Eye Diseases","Annual prevalence of treated diabetic eye diseases","All Diabetic eye diseases","85 years and older","All genders","All races","All patients","Total","%","Crude Prevalence","0.81",,,"0.71","0.91",,"31700","34","TCOND","CDXC2","QDXC2","R2_ALL","CRDPREV","AGE85PLUS","GALL","ALLRACE","RFALL","RFTOT","POINT(-74.2736912879996 40.1305700480004)"
"2014","2014","GA","Georgia","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.06",,,"0.05","0.06","400","680600","13","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2014","2014","VT","Vermont","MAX","Service Utilization","Cataract Surgery","Percentage of people with diagnosed cataract who had a treatment claim","Cataract surgery","65-84 years","Female","All races","Cataract","Yes","%","Crude Prevalence","21.95",,,"10.56","37.61","0","0","50","TUTL","CCATS","QCATS","RCATSUR","CRDPREV","AGE6584","GF","ALLRACE","RFCAT","RFYES","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","LA","Louisiana","MAX","Eye Health Conditions","Other Eye Disorders","Annual prevalence of treated other eye disorders","All Other eye disorders","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","1.04",,,"0.93","1.14",,"36500","22","TCOND","CDXC17","QDXC17","R17_ALL","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-92.4456800709996 31.3126606440004)"
"2014","2014","TN","Tennessee","MAX","Eye Health Conditions","Orbital and External Disease","Annual prevalence of treated orbital and external disease","Disorders of the globe","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","0.02",,,"0.01","0.03",,"143900","47","TCOND","CDXC14","QDXC14","R14_6","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-85.7744909139996 35.6809405800004)"
"2014","2014","SD","South Dakota","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","Wet-form age-related macular degeneration","65-84 years","Female","All races","All patients","Total","%","Crude Prevalence","0.85",,,"0.63","1.12",,"5700","46","TCOND","CDXC3","QDXC3","R3_4","CRDPREV","AGE6584","GF","ALLRACE","RFALL","RFTOT","POINT(-100.373530636999 44.3531300530004)"
"2013","2013","VT","Vermont","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","Other corneal disorders","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0.15",,,"0.12","0.19",,"41300","50","TCOND","CDXC16","QDXC16","R16_3","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","VT","Vermont","MAX","Eye Health Conditions","Injury, Burns and Surgical Complications of the Eye","Annual prevalence of treated injury, burns and surgical complications of the eye","Ocular injury","All ages","Male","All races","All patients","Total","%","Crude Prevalence","0.99",,,"0.92","1.07",,"66500","50","TCOND","CDXC10","QDXC10","R10_1","CRDPREV","AGEALL","GM","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Age Related Macular Degeneration","Annual prevalence of treated age related macular degeneration","All Age-related macular degeneration (AMD)","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.34",,,"0.31","0.37",,"158300","16","TCOND","CDXC3","QDXC3","R3_ALL","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","TN","Tennessee","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Stereo fundus exam","40-64 years","Female","All races","Diabetes","Yes","%","Crude Prevalence","10.09",,,"9.62","10.57","1600","15600","47","TUTL","CTEST","QTEST","RFUN","CRDPREV","AGE4064","GF","ALLRACE","RFDM","RFYES","POINT(-85.7744909139996 35.6809405800004)"
"2013","2013","MI","Michigan","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Malignant neoplasm","40-64 years","Male","All races","All patients","Total","%","Crude Prevalence","0.01",,,"0","0.02",,"131600","26","TCOND","CDXC15","QDXC15","R15_1","CRDPREV","AGE4064","GM","ALLRACE","RFALL","RFTOT","POINT(-84.7143902699996 44.6613195430005)"
"2014","2014","MN","Minnesota","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Photodynamic therapy","65-84 years","Male","All races","Hypertension and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"27","TUTL","CAMDTX","QAMD","RPHOTO","CRDPREV","AGE6584","GM","ALLRACE","RFHTAMD","RFYES","POINT(-94.7942005029996 46.3556487360004)"
"2014","2014","ID","Idaho","MAX","Service Utilization","Imaging or diagnostic test","Percentage of people who had an eye or vision diagnostic test claim","Gonioscopy","18-39 years","All genders","All races","Hypertension","Yes","%","Crude Prevalence","0",,,"0","0.51","0","700","16","TUTL","CTEST","QTEST","RGONIO","CRDPREV","AGE1839","GALL","ALLRACE","RFHT","RFYES","POINT(-114.363730041999 43.6826300050004)"
"2013","2013","ID","Idaho","MAX","Eye Health Conditions","Cancer and Neoplasms of the Eye","Annual prevalence of treated cancer and neoplasms of the eye","Benign neoplasm","40-64 years","All genders","All races","All patients","Total","%","Crude Prevalence","0",,,"0","0.01",,"31600","16","TCOND","CDXC15","QDXC15","R15_2","CRDPREV","AGE4064","GALL","ALLRACE","RFALL","RFTOT","POINT(-114.363730041999 43.6826300050004)"
"2014","2014","MO","Missouri","MAX","Service Utilization","Treatment for age related macular degeneration","Percentage of people with diagnosed AMD who had a treatment claim","Laser surgery","18-39 years","Male","All races","Diabetes and AMD","Yes","%","Crude Prevalence",,"?","Some estimates are not shown due to small sample size",,,,,"29","TUTL","CAMDTX","QAMD","RLASER","CRDPREV","AGE1839","GM","ALLRACE","RFDMAMD","RFYES","POINT(-92.5663000529996 38.6357907760004)"
"2013","2013","IN","Indiana","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Other/unspecified glaucoma","85 years and older","Male","All races","All patients","Total","%","Crude Prevalence","0.18",,,"0.07","0.37",,"3900","18","TCOND","CDXC5","QDXC5","R5_9","CRDPREV","AGE85PLUS","GM","ALLRACE","RFALL","RFTOT","POINT(-86.1499601939996 39.7669104520004)"
"2013","2013","CT","Connecticut","MAX","Service Utilization","Eye Exams","Proportion of patients who had an eye exam in selected year","By any provider type","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","30.11",,,"29.8","30.43",,"83300","9","TUTL","CUTLEX","QUTLEX","REXANY","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-72.6498409519996 41.5626610200004)"
"2013","2013","OK","Oklahoma","MAX","Eye Health Conditions","Cornea Disorders","Annual prevalence of treated cornea disorders","All Cornea disorders","All ages","All genders","All races","All patients","Total","%","Crude Prevalence","0.14",,,"0.14","0.15",,"1009600","40","TCOND","CDXC16","QDXC16","R16_ALL","CRDPREV","AGEALL","GALL","ALLRACE","RFALL","RFTOT","POINT(-97.5210702139996 35.4720313560004)"
"2014","2014","VT","Vermont","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","All Cataracts","18-39 years","Female","All races","All patients","Total","%","Crude Prevalence","0.37",,,"0.3","0.44",,"29400","50","TCOND","CDXC6","QDXC6","R6_ALL","CRDPREV","AGE1839","GF","ALLRACE","RFALL","RFTOT","POINT(-72.5176407909996 43.6253812390004)"
"2014","2014","GA","Georgia","MAX","Eye Health Conditions","Cataracts","Annual prevalence of treated cataracts","Non-congenital cataract","All ages","Female","All races","All patients","Total","%","Crude Prevalence","0.31",,,"0.3","0.32",,"1136400","13","TCOND","CDXC6","QDXC6","R6_2","CRDPREV","AGEALL","GF","ALLRACE","RFALL","RFTOT","POINT(-83.6275803459996 32.8396810930004)"
"2013","2013","UT","Utah","MAX","Eye Health Conditions","Disorders of Refraction and Accommodation","Annual prevalence of treated disorders of refraction and accommodation","Hypermetropia","40-64 years","Female","All races","All patients","Total","%","Crude Prevalence","1.37",,,"1.23","1.52",,"26000","49","TCOND","CDXC7","QDXC7","R7_2","CRDPREV","AGE4064","GF","ALLRACE","RFALL","RFTOT","POINT(-111.587130634999 39.3607001710004)"
"2014","2014","MS","Mississippi","MAX","Eye Health Conditions","Glaucoma","Annual prevalence of treated glaucoma","Open-angle glaucoma","65-84 years","Male","All races","All patients","Total","%","Crude Prevalence","0.58",,,"0.48","0.69",,"22300","28","TCOND","CDXC5","QDXC5","R5_1","CRDPREV","AGE6584","GM","ALLRACE","RFALL","RFTOT","POINT(-89.5380308249996 32.7455100990004)"
